Announcement: AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study

ბოლო განახლება: 28/08/2026 19:31

ავტორი:

0 Min Read

A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in primary care. The study highlights the gap between AI capability and real-world clinical effectiveness. — Photo by www.kaboompics.com on Pexels (Pexels License)

1 min read|46 words

A pragmatic cluster-randomized trial in Kenya (Nature Medicine, 2026) found that ChatGPT-4o-assisted clinical decision support did NOT significantly reduce 14-day treatment failure vs. standard care. This challenges assumptions about AI effectiveness in primary care—implementation matters more than technology.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study →

Share This Article

ავტორი:Prof. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.